The U.S. Veterinary Point of Care Diagnostics Market was valued at USD 1.04 billion in 2024, and is projected to reach USD 1.78 billion by 2030, rising at a CAGR of 9.15%. The market's growth is predominantly fueled by a surge in spending on pet-related products and services, an expanding number of pet owners, technological advancements, and a strong demand for point-of-care diagnostics.
The rise in the companion animal population is anticipated to drive demand for veterinary healthcare services and increase overall pet spending. Pet owners in the U.S., according to 2024 statistics published by the American Pet Products Association (APPA), are estimated to be spending more than USD 150 billion on their pets, about a 66% rise from the USD 90.5 billion expenditure in 2018. Furthermore, pet owners in the country are estimated to spend about USD 39 billion on veterinary care services & products in 2024. Diagnostic tests like point-of-care (POC) provide immediate results and clinically relevant information without needing a core diagnostic laboratory. Therefore, they can reduce the cost and time associated with veterinary diagnosis. The lateral flow technology applied in POC veterinary lateral flow devices and dipsticks has been used for decades to diagnose infectious diseases among animals.
Moreover, the high number of veterinary patient visits and developed veterinary healthcare infrastructure are further expected to fuel the market growth. Companies are investing in R&D to develop point-of-care diagnostic equipment. For instance, IDEXX developed SDMA test kits, which use AI to assess kidney functions in cats and dogs. Zoetis has a pipeline of point-of-care diagnostics, which is expected to be launched in the coming years. Heska also launched a range of point-of-care diagnostic products to broaden its portfolio.
Another continuously evolving driver of this diagnostic sector is the emergence of novel technologiesfor advancing POC diagnostics in animals. For instance, researchers from Wyss Research Institute at Harvard College have developed a POC diagnostic technology, directEsense, for application in veterinary health. The technology simplifies the diagnostic process by utilizing an electrically active chemical layer on biosensor surfaces to directly detect disease biomarkers and pathogens and eliminates the need for detection labels; this product enhances electrical conductivity and reduces costs associated with traditional diagnostic methods. This research focuses on detecting unique blood serum proteins in companion animals suffering from musculoskeletal injuries and infections. The parties are now aiming for efficient product development and potential future human and environmental health diagnostics applications.
Furthermore, some other advancements, like artificial intelligence (AI), which enhances the speed and accuracy of diagnoses through real-time analysis of medical data, such as X-rays and blood tests, are expected to act as catalysts for future industry growth. Molecular diagnostics facilitate early disease detection by identifying specific pathogens and genetic markers, facilitating personalized medicine tailored to individual animals.
This product will be delivered within 2 business days.
The rise in the companion animal population is anticipated to drive demand for veterinary healthcare services and increase overall pet spending. Pet owners in the U.S., according to 2024 statistics published by the American Pet Products Association (APPA), are estimated to be spending more than USD 150 billion on their pets, about a 66% rise from the USD 90.5 billion expenditure in 2018. Furthermore, pet owners in the country are estimated to spend about USD 39 billion on veterinary care services & products in 2024. Diagnostic tests like point-of-care (POC) provide immediate results and clinically relevant information without needing a core diagnostic laboratory. Therefore, they can reduce the cost and time associated with veterinary diagnosis. The lateral flow technology applied in POC veterinary lateral flow devices and dipsticks has been used for decades to diagnose infectious diseases among animals.
Moreover, the high number of veterinary patient visits and developed veterinary healthcare infrastructure are further expected to fuel the market growth. Companies are investing in R&D to develop point-of-care diagnostic equipment. For instance, IDEXX developed SDMA test kits, which use AI to assess kidney functions in cats and dogs. Zoetis has a pipeline of point-of-care diagnostics, which is expected to be launched in the coming years. Heska also launched a range of point-of-care diagnostic products to broaden its portfolio.
Another continuously evolving driver of this diagnostic sector is the emergence of novel technologiesfor advancing POC diagnostics in animals. For instance, researchers from Wyss Research Institute at Harvard College have developed a POC diagnostic technology, directEsense, for application in veterinary health. The technology simplifies the diagnostic process by utilizing an electrically active chemical layer on biosensor surfaces to directly detect disease biomarkers and pathogens and eliminates the need for detection labels; this product enhances electrical conductivity and reduces costs associated with traditional diagnostic methods. This research focuses on detecting unique blood serum proteins in companion animals suffering from musculoskeletal injuries and infections. The parties are now aiming for efficient product development and potential future human and environmental health diagnostics applications.
Furthermore, some other advancements, like artificial intelligence (AI), which enhances the speed and accuracy of diagnoses through real-time analysis of medical data, such as X-rays and blood tests, are expected to act as catalysts for future industry growth. Molecular diagnostics facilitate early disease detection by identifying specific pathogens and genetic markers, facilitating personalized medicine tailored to individual animals.
U.S. Veterinary Point of Care Diagnostics Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2018 to 2030. For this report, the analyst has segmented the U.S. intravenous infusion pump market based on product, animal type, sample type, indication, testing category, and end-use:Product Outlook (Revenue, USD Million, 2018-2030)
- Consumables, Reagents, & Kits
- Instruments & Devices
Animal Type Outlook (Revenue, USD Million, 2018-2030)
- Companion Animals
- Dogs
- Cats
- Horses
- Others
- Livestock Animals
- Cattle
- Swine
- Poultry
Sample Type Outlook (Revenue, USD Million, 2018-2030)
- Blood/Plasma/Serum
- Urine
- Fecal
- Others
Indication Outlook (Revenue, USD Million, 2018-2030)
- Infectious Disease
- General Ailments
- Others
Testing Category Outlook (Revenue, USD Million, 2018-2030)
- Hematology
- Diagnostic Imaging
- Bacteriology
- Virology
- Cytology
- Clinical Chemistry
- Parasitology
- Serology
- Others
End-Use Outlook (Revenue, USD Million, 2018-2030)
- Veterinary Hospitals & Clinics
- Home Care Settings
- Others
This report addresses:
- Market intelligence to enable effective decision-making.
- Market estimates and forecasts from 2018 to 2030.
- Growth opportunities and trend analyses.
- Segment and regional revenue forecasts for market assessment.
- Competition strategy and market share analysis.
- Product innovation listings for you to stay ahead of the curve.
- COVID-19's impact and how to sustain in this fast-evolving market.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Veterinary point of care diagnostics Market Variables, Trends, & Scope
Chapter 4. U.S. Veterinary point of care diagnostics Market Product Estimates & Trend Analysis
Chapter 5. U.S. Veterinary point of care diagnostics Market: Animal Type Outlook Estimates & Trend Analysis
Chapter 6. U.S. Veterinary point of care diagnostics Market Sample Type Estimates & Trend Analysis
Chapter 7. U.S. Veterinary point of care diagnostics Market Indication Estimates & Trend Analysis
Chapter 8. U.S. Veterinary point of care diagnostics Market Testing Category Estimates & Trend Analysis
Chapter 9. U.S. Veterinary point of care diagnostics Market End-use Estimates & Trend Analysis
Chapter 10. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies profiled in this U.S. Veterinary Point of Care Diagnostics market report include:- Zoetis Inc.
- IDEXX
- Thermo Fisher Scientific Inc.
- Heska Corp
- Phibro Animal Health Corporation
- Blair Milling and Elevator Co., Inc.
- NeuroLogica Corp
- NEOGEN Corporation
- Marshfield Labs
- ProtaTek International, Inc.
- Texas A&M Veterinary Medical Diagnostic Laboratory
- VCA, Inc
- University of Minnesota
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | February 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 1.04 Billion |
| Forecasted Market Value ( USD | $ 1.78 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | United States |
| No. of Companies Mentioned | 13 |
